|
|
Volumn 34, Issue 5, 2002, Pages 1420-1421
|
|
Gemcitabine in models of acute and accelerated rejection
a
a
a
b
a
a,c
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GEMCITABINE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
IMMUNOSUPPRESSIVE AGENT;
ACUTE DISEASE;
ALLOGRAFT;
ANASTOMOSIS;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CYTOTOXICITY;
DISEASE MODEL;
DONOR;
DRUG EFFECT;
GRAFT REJECTION;
GREAT BLOOD VESSEL;
HEART;
HEART FUNCTION;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY ALLOGRAFT;
KIDNEY GRAFT;
LYMPHOCYTE;
MICROSURGERY;
NEPHRECTOMY;
PALPATION;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
SKIN GRAFT;
SURVIVAL;
TIME;
ALLOTRANSPLANTATION;
ANIMAL;
ARTICLE;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOLOGY;
LEWIS RAT;
PHYSIOLOGY;
RAT;
RAT STRAIN;
ACUTE DISEASE;
ANIMAL;
CYTOTOXICITY, IMMUNOLOGIC;
DEOXYCYTIDINE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEART TRANSPLANTATION;
IMMUNOSUPPRESSIVE AGENTS;
RATS;
RATS, INBRED LEW;
RATS, INBRED STRAINS;
TIME FACTORS;
TRANSPLANTATION, HOMOLOGOUS;
ANIMALS;
|
|
EID: 0035993576
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02911-1 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (3)
|
